These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8385093)

  • 1. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis.
    Boaretti M; Canepari P; Lleò MM; Satta G
    J Antimicrob Chemother; 1993 Feb; 31(2):227-35. PubMed ID: 8385093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032).
    Canepari P; Boaretti M; Lleó MM; Satta G
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1220-6. PubMed ID: 2168145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
    Laganas V; Alder J; Silverman JA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium.
    Paganelli FL; van de Kamer T; Brouwer EC; Leavis HL; Woodford N; Bonten MJ; Willems RJ; Hendrickx AP
    Int J Antimicrob Agents; 2017 Mar; 49(3):355-363. PubMed ID: 28188831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae.
    Boaretti M; Canepari P
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2068-72. PubMed ID: 8540717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoteichoic acid as a target for antimicrobial action.
    Canepari P; Boaretti M
    Microb Drug Resist; 1996; 2(1):85-9. PubMed ID: 9158727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin tolerance and modification of lipoteichoic acid associated with expression of vancomycin resistance in VanB-type Enterococcus faecium D366.
    Gutmann L; Al-Obeid S; Billot-Klein D; Ebnet E; Fischer W
    Antimicrob Agents Chemother; 1996 Jan; 40(1):257-9. PubMed ID: 8787919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of daptomycin binding proteins (DBPs) from the membrane of Enterococcus hirae.
    Boaretti M; Canepari P
    New Microbiol; 2000 Jul; 23(3):305-17. PubMed ID: 10939046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to daptomycin in Enterococcus faecium.
    Montero CI; Stock F; Murray PR
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1167-70. PubMed ID: 18180351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
    Rand KH; Houck HJ; Silverman JA
    J Antimicrob Chemother; 2007 May; 59(5):1017-20. PubMed ID: 17369277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.
    Woods RJ; Patel TS; Nagel JL; Newton DW; Read AF
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):226-228. PubMed ID: 29331166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
    Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.
    Panesso D; Reyes J; Gaston EP; Deal M; Londoño A; Nigo M; Munita JM; Miller WR; Shamoo Y; Tran TT; Arias CA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7327-34. PubMed ID: 26369959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics.
    Sakoulas G; Kumaraswamy M; Nonejuie P; Werth BJ; Rybak MJ; Pogliano J; Rice LB; Nizet V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6132-9. PubMed ID: 26195528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an
    Belley A; Lalonde-Séguin D; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.